Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: A systematic review

Amir Shroufi, Rajiv Chowdhury, Raghupathy Anchala, Sarah Stevens, Patricia Blanco, Tha Han, Louis Niessen, Oscar H. Franco

Research output: Contribution to journalArticle

Abstract

Background: While there is good evidence to show that behavioural and lifestyle interventions can reduce cardiovascular disease risk factors in affluent settings, less evidence exists in lower income settings.This study systematically assesses the evidence on cost-effectiveness for preventive cardiovascular interventions in low and middle-income settings. Methods. Design: Systematic review of economic evaluations on interventions for prevention of cardiovascular disease.Data sources: PubMed, Web of Knowledge, Scopus and Embase, Opensigle, the Cochrane database, Business Source Complete, the NHS Economic Evaluations Database, reference lists and email contact with experts.Eligibility criteria for selecting studies: we included economic evaluations conducted in adults, reporting the effect of interventions to prevent cardiovascular disease in low and middle income countries as defined by the World Bank. The primary outcome was a change in cardiovascular disease occurrence including coronary heart disease, heart failure and stroke.Data extraction: After selection of the studies, data were extracted by two independent investigators using a previously constructed tool and quality was evaluated using Drummond's quality assessment score. Results: From 9731 search results we found 16 studies, which presented economic outcomes for interventions to prevent cardiovascular disease in low and middle income settings, with most of these reporting positive cost effectiveness results.When the same interventions were evaluated across settings, within and between papers, the likelihood of an intervention being judged cost effective was generally lower in regions with lowest gross national income. While population based interventions were in most cases more cost effective, cost effectiveness estimates for individual pharmacological interventions were overall based upon a stronger evidence base. Conclusions: While more studies of cardiovascular preventive interventions are needed in low and mid income settings, the available high-level of evidence supports a wide range of interventions for the prevention of cardiovascular disease as being cost effective across all world regions.

Original languageEnglish (US)
Article number285
JournalBMC Public Health
Volume13
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Cost-Benefit Analysis
Cardiovascular Diseases
Costs and Cost Analysis
Databases
United Nations
Information Storage and Retrieval
PubMed
Coronary Disease
Life Style
Heart Failure
Stroke
Economics
Research Personnel
Pharmacology
Population

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries : A systematic review. / Shroufi, Amir; Chowdhury, Rajiv; Anchala, Raghupathy; Stevens, Sarah; Blanco, Patricia; Han, Tha; Niessen, Louis; Franco, Oscar H.

In: BMC Public Health, Vol. 13, No. 1, 285, 2013.

Research output: Contribution to journalArticle

Shroufi, Amir ; Chowdhury, Rajiv ; Anchala, Raghupathy ; Stevens, Sarah ; Blanco, Patricia ; Han, Tha ; Niessen, Louis ; Franco, Oscar H. / Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries : A systematic review. In: BMC Public Health. 2013 ; Vol. 13, No. 1.
@article{88422333d00d4f108c5b95278f1b7422,
title = "Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: A systematic review",
abstract = "Background: While there is good evidence to show that behavioural and lifestyle interventions can reduce cardiovascular disease risk factors in affluent settings, less evidence exists in lower income settings.This study systematically assesses the evidence on cost-effectiveness for preventive cardiovascular interventions in low and middle-income settings. Methods. Design: Systematic review of economic evaluations on interventions for prevention of cardiovascular disease.Data sources: PubMed, Web of Knowledge, Scopus and Embase, Opensigle, the Cochrane database, Business Source Complete, the NHS Economic Evaluations Database, reference lists and email contact with experts.Eligibility criteria for selecting studies: we included economic evaluations conducted in adults, reporting the effect of interventions to prevent cardiovascular disease in low and middle income countries as defined by the World Bank. The primary outcome was a change in cardiovascular disease occurrence including coronary heart disease, heart failure and stroke.Data extraction: After selection of the studies, data were extracted by two independent investigators using a previously constructed tool and quality was evaluated using Drummond's quality assessment score. Results: From 9731 search results we found 16 studies, which presented economic outcomes for interventions to prevent cardiovascular disease in low and middle income settings, with most of these reporting positive cost effectiveness results.When the same interventions were evaluated across settings, within and between papers, the likelihood of an intervention being judged cost effective was generally lower in regions with lowest gross national income. While population based interventions were in most cases more cost effective, cost effectiveness estimates for individual pharmacological interventions were overall based upon a stronger evidence base. Conclusions: While more studies of cardiovascular preventive interventions are needed in low and mid income settings, the available high-level of evidence supports a wide range of interventions for the prevention of cardiovascular disease as being cost effective across all world regions.",
author = "Amir Shroufi and Rajiv Chowdhury and Raghupathy Anchala and Sarah Stevens and Patricia Blanco and Tha Han and Louis Niessen and Franco, {Oscar H.}",
year = "2013",
doi = "10.1186/1471-2458-13-285",
language = "English (US)",
volume = "13",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries

T2 - A systematic review

AU - Shroufi, Amir

AU - Chowdhury, Rajiv

AU - Anchala, Raghupathy

AU - Stevens, Sarah

AU - Blanco, Patricia

AU - Han, Tha

AU - Niessen, Louis

AU - Franco, Oscar H.

PY - 2013

Y1 - 2013

N2 - Background: While there is good evidence to show that behavioural and lifestyle interventions can reduce cardiovascular disease risk factors in affluent settings, less evidence exists in lower income settings.This study systematically assesses the evidence on cost-effectiveness for preventive cardiovascular interventions in low and middle-income settings. Methods. Design: Systematic review of economic evaluations on interventions for prevention of cardiovascular disease.Data sources: PubMed, Web of Knowledge, Scopus and Embase, Opensigle, the Cochrane database, Business Source Complete, the NHS Economic Evaluations Database, reference lists and email contact with experts.Eligibility criteria for selecting studies: we included economic evaluations conducted in adults, reporting the effect of interventions to prevent cardiovascular disease in low and middle income countries as defined by the World Bank. The primary outcome was a change in cardiovascular disease occurrence including coronary heart disease, heart failure and stroke.Data extraction: After selection of the studies, data were extracted by two independent investigators using a previously constructed tool and quality was evaluated using Drummond's quality assessment score. Results: From 9731 search results we found 16 studies, which presented economic outcomes for interventions to prevent cardiovascular disease in low and middle income settings, with most of these reporting positive cost effectiveness results.When the same interventions were evaluated across settings, within and between papers, the likelihood of an intervention being judged cost effective was generally lower in regions with lowest gross national income. While population based interventions were in most cases more cost effective, cost effectiveness estimates for individual pharmacological interventions were overall based upon a stronger evidence base. Conclusions: While more studies of cardiovascular preventive interventions are needed in low and mid income settings, the available high-level of evidence supports a wide range of interventions for the prevention of cardiovascular disease as being cost effective across all world regions.

AB - Background: While there is good evidence to show that behavioural and lifestyle interventions can reduce cardiovascular disease risk factors in affluent settings, less evidence exists in lower income settings.This study systematically assesses the evidence on cost-effectiveness for preventive cardiovascular interventions in low and middle-income settings. Methods. Design: Systematic review of economic evaluations on interventions for prevention of cardiovascular disease.Data sources: PubMed, Web of Knowledge, Scopus and Embase, Opensigle, the Cochrane database, Business Source Complete, the NHS Economic Evaluations Database, reference lists and email contact with experts.Eligibility criteria for selecting studies: we included economic evaluations conducted in adults, reporting the effect of interventions to prevent cardiovascular disease in low and middle income countries as defined by the World Bank. The primary outcome was a change in cardiovascular disease occurrence including coronary heart disease, heart failure and stroke.Data extraction: After selection of the studies, data were extracted by two independent investigators using a previously constructed tool and quality was evaluated using Drummond's quality assessment score. Results: From 9731 search results we found 16 studies, which presented economic outcomes for interventions to prevent cardiovascular disease in low and middle income settings, with most of these reporting positive cost effectiveness results.When the same interventions were evaluated across settings, within and between papers, the likelihood of an intervention being judged cost effective was generally lower in regions with lowest gross national income. While population based interventions were in most cases more cost effective, cost effectiveness estimates for individual pharmacological interventions were overall based upon a stronger evidence base. Conclusions: While more studies of cardiovascular preventive interventions are needed in low and mid income settings, the available high-level of evidence supports a wide range of interventions for the prevention of cardiovascular disease as being cost effective across all world regions.

UR - http://www.scopus.com/inward/record.url?scp=84875352060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875352060&partnerID=8YFLogxK

U2 - 10.1186/1471-2458-13-285

DO - 10.1186/1471-2458-13-285

M3 - Article

C2 - 23537334

AN - SCOPUS:84875352060

VL - 13

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

IS - 1

M1 - 285

ER -